Title : Effect of interleukin-1 alpha and tumour necrosis factor-alpha on cisplatin-induced ERCC-1 mRNA expression in a human ovarian carcinoma cell line.

Pub. Date : 1998 Jul-Aug

PMID : 9703867






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Effect of interleukin-1 alpha and tumour necrosis factor-alpha on cisplatin-induced ERCC-1 mRNA expression in a human ovarian carcinoma cell line. Cisplatin ERCC excision repair 1, endonuclease non-catalytic subunit Homo sapiens
2 Enhanced expression of the human excision repair enzyme ERCC-1 is associated with cellular and clinical resistance to cisplatin in human ovarian cancer. Cisplatin ERCC excision repair 1, endonuclease non-catalytic subunit Homo sapiens
3 We therefore began to examine the effect of some cisplatin resistance modulators on cisplatin-induced ERCC-1 mRNA expression in the human ovarian carcinoma cell line, A2780/CP70. Cisplatin ERCC excision repair 1, endonuclease non-catalytic subunit Homo sapiens
4 Cisplatin exposure to A2780/CP70 cells in culture resulted in a four- to five-fold induction for steady-state ERCC-1 mRNA, that was dose- and time-dependent. Cisplatin ERCC excision repair 1, endonuclease non-catalytic subunit Homo sapiens
5 IL-1 alpha inhibited cisplatin induction of ERCC-1 mRNA levels in our system. Cisplatin ERCC excision repair 1, endonuclease non-catalytic subunit Homo sapiens
6 These findings suggest that the enhancement effect of some agents on cisplatin sensitivity in ovarian tumour cells may be through downregulating ERCC-1 expression. Cisplatin ERCC excision repair 1, endonuclease non-catalytic subunit Homo sapiens